The Road to Drug Development

You don’t want to miss this discussion with our panel of industry leaders. No Images? Click here Less than one week away! Join Yale, PAREXEL and Health Advances in an interactive discussion of partnering and commercialization strategies for early stage medtech and biotech entrepreneurs. We invite you to engage on when and why to partner and how to develop product strategies to set the path for clinical and commercial success. Register For Free Now! Topics for discussion include: Best practices for emerging biopharma companies when exploring funding from venture firms or larger pharmaceutical partners Critical commercial success factors for maximizing company value Weighing funding vs long-term partnership options Identifying the right exit strategy based upon internal expertise and corporate objectives Speakers: Peyton Howell, Chief Commercial and Strategy Officer, PAREXEL International Marc Pelletier, Chief Executive Officer & Chief Scientific Officer, Aeromics Wyatt Gotbetter, Partner, Health Advances John G. Houston, President and Chief Executive Officer, Arvinas Donnie McGrath, M.D., Chief of Corporate Strategy & Business Development Yale Office of Cooperative Research 433 Temple St New Haven, CT 06511 ocr@yale.edu You are receiving this email because you have expressed interest in innovation, entrepreneurship and opportunities for researchers at Yale.